The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK

摘要

Objectives. To examine the costs and benefits associated with long-term etanercept (ETN) treatment in patients with severe ankylosing spondylitis (AS) in the UK in accordance with the BSR guidelines.